0001628280-23-036052.txt : 20231101 0001628280-23-036052.hdr.sgml : 20231101 20231101172953 ACCESSION NUMBER: 0001628280-23-036052 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231019 FILED AS OF DATE: 20231101 DATE AS OF CHANGE: 20231101 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: DE GREEF RODERICK CENTRAL INDEX KEY: 0001241181 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36362 FILM NUMBER: 231369342 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: BIOLIFE SOLUTIONS INC CENTRAL INDEX KEY: 0000834365 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 943076866 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 3303 MONTE VILLA PARKWAY STREET 2: SUITE 310 CITY: BOTHELL STATE: WA ZIP: 98021 BUSINESS PHONE: 4254011400 MAIL ADDRESS: STREET 1: 3303 MONTE VILLA PARKWAY STREET 2: SUITE 310 CITY: BOTHELL STATE: WA ZIP: 98021 FORMER COMPANY: FORMER CONFORMED NAME: BIOLIFE SOLUTION INC DATE OF NAME CHANGE: 20030113 FORMER COMPANY: FORMER CONFORMED NAME: CRYOMEDICAL SCIENCES INC DATE OF NAME CHANGE: 19920703 4 1 wk-form4_1698874183.xml FORM 4 X0508 4 2023-10-19 0 0000834365 BIOLIFE SOLUTIONS INC BLFS 0001241181 DE GREEF RODERICK 3303 MONTE VILLA PARKWAY SUITE 310 BOTHELL WA 98021 1 1 0 0 President and CEO 0 Common Stock 2023-10-19 4 A 0 394856 A 442539 D Restricted Stock Award 0 2023-10-19 4 A 0 394856 0 A Common Stock 394856 394856 D The restricted stock was granted pursuant to the BioLife Solutions 2023 Omnibus Performance Incentive Plan and vests 25% on the first anniversary of the grant date and thereafter quarterly, in 12 equal quarterly installments. The restricted stock was granted to the reporting person as part of their employment agreement. This reflects the total amount beneficially owned by the reporting person as of October 19, 2023. Previous Form 4's filed by the reporting person before October 19, 2023 did not reflect the acquisition of 2,421 shares. The restricted stock was granted pursuant to the Executive Employment Agreement. The restricted stock will vest in equal annual installments so long as the reporting owner remains employed by the registrant through January 1, 2027. /s/ Roderick de Greef 2023-11-01